StemCyte India Therapeutics Pvt Ltd USA based company World class stems cell banking It was born on the 1st Vibrant Gujarat Summit by Honorable Prime Minister Shri Narendrabhai Modi It was established in 2008 and it is a joint venture between StemCyte Inc USA Apollo Hospital Enterprises Ltd and Cadila Pharmaceuticals Ltd We have patented Plasma depletion technology design to deliver maximum number of high quality stem cell Ensures cell recovery up to 99 96 - unmatched in industry StemCyte is the world leader in Umbilical cord blood transplant It is the only company with the experience of treating 58 Hematopoetic blood disorders like Thelassemia CGD HLH Fanconi Anemia Immune Defiency Disorder and Infantile etc 8226 We have facilitated as many as 2000 transplant across 315 centers in 38 countries across 6 continents 8226 The company is backed by a world-class doctor fraternity within the Apollo group 8226 We have 75 000 units in Public amp Private inventories across the globe 8226 StemCyte offers a complete stem cell solution from banking to application 8226 We have a trained transplant coordination team together with trained staff at all touch points works to achieve best possible outcomes 8226 International accreditation FDA and AABB approved certifications and licenses that endorse commitment to quality 8226 We adopt a unique 8220 hybrid 8221 model involving public banking private banking therapeutic application and clinical trials Please find out our latest offers on stem cell banking Website www stemcyteindia com Toll-free number 1-860-4204206 Email marketing stemcyteindia com